Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026629
Filing Date
2021-11-15
Accepted
2021-11-15 08:19:16
Documents
41
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20210930_10q.htm   iXBRL 10-Q 677536
2 EXHIBIT 10.1 ex_295742.htm EX-10.1 53426
3 EXHIBIT 31.1 ex_279494.htm EX-31.1 19514
4 EXHIBIT 31.2 ex_279495.htm EX-31.2 14478
5 EXHIBIT 32.1 ex_279496.htm EX-32.1 10503
  Complete submission text file 0001437749-21-026629.txt   3650206

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20210930.xsd EX-101.SCH 33570
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20210930_cal.xml EX-101.CAL 19074
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20210930_def.xml EX-101.DEF 258587
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20210930_lab.xml EX-101.LAB 242637
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20210930_pre.xml EX-101.PRE 273046
11 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20210930_10q_htm.xml XML 397854
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 211406533
SIC: 2834 Pharmaceutical Preparations